What ultimate human questions do the 2026 Breakthrough Prizes illuminate?

On April 18 local time, the 12th Breakthrough Prize Ceremony was held at Barker Hangar in Santa Monica, California, USA. Dubbed the 'Oscars of Science,' this annual event brought together world-leading scientists, technology leaders, and prominent figures from business and entertainment. This year marks the 14th anniversary of the prize. Six awards—each worth $3 million, triple the Nobel Prize’s monetary value—were bestowed upon outstanding discoveries in life sciences, fundamental physics, and mathematics. Additionally, fifteen early-career physicists and mathematicians received the New Horizons Prizes, each valued at $100,000; three women mathematicians who had recently completed their PhDs each received the $50,000 Maryam Mirzakhani New Frontiers Prize. One line from the award citation reads: 'The laureates’ discoveries are significantly advancing the growth of human knowledge.' So precisely what ultimate questions are these discoveries approaching? Image source: http://breakthroughprize.org How far are we from 'designing life'? This year’s Breakthrough Prizes in Life Sciences awarded three prizes, each probing a distinct layer of humanity’s inquiry into the 'code of life.' First layer: Can we repair the 'coding errors' written by nature? Jean Bennett, Katherine A. High, and Albert Maguire were honored for leading the development of the world’s first FDA-approved gene replacement therapy—designed to treat inherited retinal disease causing Leber congenital amaurosis (LCA), restoring vision to many patients who would otherwise have become completely blind in early adulthood. LCA is caused by defects in the RPE65 gene, impairing the retina’s ability to convert light signals into neural signals. Prior to the work of these three scientists, this condition meant irreversible, progressive blindness. Their therapy delivers a functional copy of the RPE65 gene into retinal cells via a viral vector, replacing the defective version. Yet this therapy addresses only one extremely rare form of inherited retinal disease. Behind countless other genetic disorders lie thousands of distinct genetic errors. The core limitation of gene replacement therapy is that it can only substitute a single missing or severely damaged gene. For more complex genetic problems, simply 'delivering a healthy gene' falls short—leading directly to the second layer of inquiry. Second layer: Can we edit genes themselves with precision—like editing text? Stuart Orkin of Boston Children’s Hospital and Swee Lay Thein of the U.S. National Heart, Lung, and Blood Institute independently discovered that the BCL11A gene acts as the master 'switch' controlling the transition from fetal to adult hemoglobin. By using gene-editing tools to suppress BCL11A, the body reactivates production of fetal hemoglobin—which remains unaffected by the mutation causing sickle cell disease.

November 7, 2024 Foreign Publication Close Reading: The 'Invisible Barrier' of the Nobel Prize—Why Does the Nobel Prize Repeatedly Face Fairness Controversies?

laureate: n. an award recipient; a poet laureate (short for Poet Laureate); adj. (literary) crowned with a laurel wreath; (literary) made of laurel leaves; honorary; v. to crown with laurels; to appoint as poet laureate All seven laureates announced this year for the scientific Nobel Prizes are men from North America and Europe. A breakdown of statistics published by the journal Nature shows that new laureates frequently operate in the orbit of older ones, and that social networks matter. The journal describes the prizes as 'globally unrepresentative'. This year, no science Nobels were awarded to women. 'It disappoints me,' astrophysicist Dame Jocelyn Bell Burnell says. She is widely regarded as having lost out on a 1974 Nobel for the discovery of pulsars in favour of two senior men, one her PhD supervisor. In 2018 she won a $3mn Breakthrough Prize—a newer rival to the Nobels—and used the cash to start a scholarship fund for physicists from under-represented backgrounds.

AISES Announces 2026 Ely S. Parker Award Winner Mary Jo Ondrechen

22 hours ago

The Advancing Indigenous Science and Engineering Society (AISES) has named Northeastern University Professor Mary Jo Ondrechen the 2026 Ely S. Parker Award recipient. Ondrechen is recognized for her research on global health challenges, including SARS-CoV-2, cancer therapies, and enzyme studies.

cen

2026-10-17

AISES Announces 2026 Ely S. Parker Award Winner Mary Jo Ondrechen

AISES Announces 2026 Ely S. Parker Award Winner Mary Jo Ondrechen

FAQ